Active Navigation Training (ANTaging)

November 24, 2023 updated by: Istituto Auxologico Italiano

Active Navigation Training: an Innovative Embodied-based Training System for Spatial Navigation in Aging

Pilot testing and development of an immersive virtual reality system for spatial navigation training in mild cognitive impairment syndrome.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Lombardia
      • Milan, Lombardia, Italy, 20145
        • Cosimo Tuena

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • clinical diagnosis of mild cognitive impairment
  • absence of severe cognitive deterioration as assessed by the Italian version of the MMSE (Magni et al. 1996)
  • age ≥ 60

Exclusion Criteria:

  • the presence of acute stroke/transient ischemic attack;
  • the presence of other concomitants severe neurological/psychiatric diseases;
  • history of traumatic brain injury with loss of consciousness;
  • physical/functional deficits that could affect the use of immersive virtual reality;
  • severe visual deficiency;
  • the presence of recurrent vertigo.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CAVE
10 immersive virtual reality sessions to train spatial memory
The training is designed to train spatial navigation and memory and in particular egocentric and allocentric processes
Active Comparator: TAU
10 paper and pencil sessions to train spatial memory
This is the usual care used to train visuospatial processes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Corsi supra-span test
Time Frame: After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
Scores range from 0 to 29.16, higher scores indicate better visuospatial learning
After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
Change in Manikin Test
Time Frame: After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
Scores range from 0 to 1, higher scores indicate better visuospatial mental rotation
After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up

Secondary Outcome Measures

Outcome Measure
Time Frame
Trail-making test part A and B
Time Frame: After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
Raccontino (6 Dicembre) (immediate-delayed-forgetting)
Time Frame: After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
Mini-mental state examination
Time Frame: After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
Digit span forward
Time Frame: After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
Corsi Block Tapping
Time Frame: After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2020

Primary Completion (Actual)

April 1, 2023

Study Completion (Actual)

July 1, 2023

Study Registration Dates

First Submitted

February 22, 2023

First Submitted That Met QC Criteria

March 3, 2023

First Posted (Actual)

March 14, 2023

Study Record Updates

Last Update Posted (Actual)

November 27, 2023

Last Update Submitted That Met QC Criteria

November 24, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 39M801

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mild Cognitive Impairment

Clinical Trials on CAVE

Subscribe